{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T12:44:59Z","timestamp":1790858699049,"version":"4.1.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T00:00:00Z","timestamp":1747094400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T00:00:00Z","timestamp":1747094400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Shanghai First Maternity and Infant Hospital, affiliated with Tongji University School of Medicine","award":["2023LYPYA05"],"award-info":[{"award-number":["2023LYPYA05"]}]},{"name":"Pudong New Area Science and Technology Development Fund","award":["PKJ2022-Y16"],"award-info":[{"award-number":["PKJ2022-Y16"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod Biol Endocrinol"],"DOI":"10.1186\/s12958-025-01404-0","type":"journal-article","created":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T00:31:13Z","timestamp":1747096273000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Comparison of the euploidy rate in preimplantation genetic testing for aneuploidy cycles following progestin-primed versus gonadotropin-releasing hormone antagonist protocol: a randomized controlled study"],"prefix":"10.1186","volume":"23","author":[{"given":"Lu","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing Yun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao Hui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernest Hung Yu","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ai","family":"Ai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi Qin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,13]]},"reference":[{"key":"1404_CR1","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1093\/humupd\/dmx017","volume":"23","author":"CB Lambalk","year":"2017","unstructured":"Lambalk CB, Banga FR, Huirne JA, Toftager M, Pinborg A, Homburg R, et al. GnRH antagonist versus long agonist protocols in IVF: a systematic review and meta-analysis accounting for patient type. Hum Reprod Update. 2017;23:560\u201379.","journal-title":"Hum Reprod Update"},{"key":"1404_CR2","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1111\/1471-0528.14622","volume":"124","author":"J Dong","year":"2017","unstructured":"Dong J, Wang Y, Chai WR, Hong QQ, Wang NL, Sun LH, et al. The pregnancy outcome of progestin-primed ovarian stimulation using 4 versus 10\u00a0mg of Medroxyprogesterone acetate per day in infertile women undergoing in vitro fertilisation: a randomised controlled trial. BJOG. 2017;124:1048\u201355.","journal-title":"BJOG"},{"key":"1404_CR3","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.fertnstert.2015.03.022","volume":"104","author":"Y Kuang","year":"2015","unstructured":"Kuang Y, Chen Q, Fu Y, Wang Y, Hong Q, Lyu Q, et al. Medroxyprogesterone acetate is an effective oral alternative for preventing premature luteinizing hormone surges in women undergoing controlled ovarian hyperstimulation for in vitro fertilization. Fertil Steril. 2015;104:62\u201370. e3.","journal-title":"Fertil Steril"},{"key":"1404_CR4","first-page":"211","volume":"23","author":"N Massin","year":"2017","unstructured":"Massin N. New stimulation regimens: endogenous and exogenous progesterone use to block the LH surge during ovarian stimulation for IVF. Hum Reprod Update. 2017;23:211\u201320.","journal-title":"Hum Reprod Update"},{"key":"1404_CR5","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1093\/humrep\/dex367","volume":"33","author":"S Yu","year":"2018","unstructured":"Yu S, Long H, Chang HY, Liu Y, Gao H, Zhu J, et al. New application of dydrogesterone as a part of a progestin-primed ovarian stimulation protocol for IVF: a randomized controlled trial including 516 first IVF\/ICSI cycles. Hum Reprod. 2018;33:229\u201337.","journal-title":"Hum Reprod"},{"key":"1404_CR6","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1093\/humrep\/dez034","volume":"34","author":"R Beguer\u00eda","year":"2019","unstructured":"Beguer\u00eda R, Garc\u00eda D, Vassena R, Rodr\u00edguez A. Medroxyprogesterone acetate versus Ganirelix in oocyte donation: a randomized controlled trial. Hum Reprod. 2019;34:872\u201380.","journal-title":"Hum Reprod"},{"key":"1404_CR7","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.fertnstert.2021.02.036","volume":"116","author":"J Giles","year":"2021","unstructured":"Giles J, Alama P, Gamiz P, Vidal C, Badia P, Pellicer A, et al. Medroxyprogesterone acetate is a useful alternative to a gonadotropin-releasing hormone antagonist in oocyte donation: a randomized, controlled trial. Fertil Steril. 2021;116:404\u201312.","journal-title":"Fertil Steril"},{"key":"1404_CR8","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1093\/humrep\/deu033","volume":"29","author":"A Capalbo","year":"2014","unstructured":"Capalbo A, Rienzi L, Cimadomo D, Maggiulli R, Elliott T, Wright G, et al. Correlation between standard blastocyst morphology, euploidy and implantation: an observational study in two centers involving 956 screened blastocysts. Hum Reprod. 2014;29:1173\u201381.","journal-title":"Hum Reprod"},{"key":"1404_CR9","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.ogc.2017.10.009","volume":"45","author":"C Sullivan-Pyke","year":"2018","unstructured":"Sullivan-Pyke C, Dokras A. Preimplantation genetic screening and preimplantation genetic diagnosis. Obstet Gynecol Clin North Am. 2018;45:113\u201325.","journal-title":"Obstet Gynecol Clin North Am"},{"key":"1404_CR10","doi-asserted-by":"crossref","unstructured":"Giles J, Cruz M, Cobo A, Vidal C, Requena A, Remohi J, et al. Medroxyprogesterone acetate: an alternative to GnRH-antagonist in oocyte vitrification for social fertility preservation and preimplantation genetic testing for aneuploidy. Reprod Biomed Online; 2023.","DOI":"10.1016\/j.rbmo.2023.04.013"},{"key":"1404_CR11","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s40001-023-01000-1","volume":"28","author":"L Wang","year":"2023","unstructured":"Wang L, Wang J, Zhang Y, Qian C, Wang X, Bai J, et al. Analysis of euploidy rates in preimplantation genetic testing for aneuploidy cycles with progestin-primed versus GnRH agonist\/antagonist protocol. Eur J Med Res. 2023;28:28.","journal-title":"Eur J Med Res"},{"key":"1404_CR12","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.rbmo.2022.03.003","volume":"45","author":"L Yang","year":"2022","unstructured":"Yang L, Luo K, Lu G, Lin G, Gong F. Euploidy rates among preimplantation genetic testing for aneuploidy cycles with oral dydrogesterone primed ovarian stimulation or GnRH antagonist protocol. Reprod Biomed Online. 2022;45:721\u20136.","journal-title":"Reprod Biomed Online"},{"key":"1404_CR13","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s12958-023-01124-3","volume":"21","author":"AH Pai","year":"2023","unstructured":"Pai AH, Sung YJ, Li CJ, Lin CY, Chang CL. Progestin primed ovarian stimulation (PPOS) protocol yields lower euploidy rate in older patients undergoing IVF. Reprod Biol Endocrinol. 2023;21:72.","journal-title":"Reprod Biol Endocrinol"},{"key":"1404_CR14","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1111\/j.1749-6632.1988.tb22263.x","volume":"541","author":"LL Veeck","year":"1988","unstructured":"Veeck LL. Oocyte assessment and biological performance. Ann N Y Acad Sci. 1988;541:259\u201374.","journal-title":"Ann N Y Acad Sci"},{"key":"1404_CR15","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1097\/00001703-199906000-00013","volume":"11","author":"DK Gardner","year":"1999","unstructured":"Gardner DK, Schoolcraft WB. Culture and transfer of human blastocysts. Curr Opin Obstet Gynecol. 1999;11:307\u201311.","journal-title":"Curr Opin Obstet Gynecol"},{"key":"1404_CR16","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1093\/humrep\/dey333","volume":"34","author":"ZQ Chen","year":"2019","unstructured":"Chen ZQ, Wang Y, Ng EHY, Zhao M, Pan JP, Wu HX, et al. A randomized triple blind controlled trial comparing the live birth rate of IVF following brief incubation versus standard incubation of gametes. Hum Reprod. 2019;34:100\u20138.","journal-title":"Hum Reprod"},{"key":"1404_CR17","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1093\/humrep\/deaa068","volume":"35","author":"A La Marca","year":"2020","unstructured":"La Marca A, Capuzzo M, Sacchi S, Imbrogno MG, Spinella F, Varricchio MT, et al. Comparison of euploidy rates of blastocysts in women treated with progestins or GnRH antagonist to prevent the luteinizing hormone surge during ovarian stimulation. Hum Reprod. 2020;35:1325\u201331.","journal-title":"Hum Reprod"},{"key":"1404_CR18","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1093\/humupd\/dmaa040","volume":"27","author":"B Ata","year":"2021","unstructured":"Ata B, Capuzzo M, Turkgeldi E, Yildiz S, La Marca A. Progestins for pituitary suppression during ovarian stimulation for ART: a comprehensive and systematic review including meta-analyses. Hum Reprod Update. 2021;27:48\u201366.","journal-title":"Hum Reprod Update"},{"key":"1404_CR19","doi-asserted-by":"publisher","first-page":"705264","DOI":"10.3389\/fendo.2021.705264","volume":"12","author":"M Du","year":"2021","unstructured":"Du M, Zhang J, Li Z, Liu X, Li J, Liu W, et al. Comparison of the cumulative live birth rates of Progestin-Primed ovarian stimulation and flexible GnRH antagonist protocols in patients with low prognosis. Front Endocrinol (Lausanne). 2021;12:705264.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1404_CR20","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1007\/s00404-018-4856-8","volume":"298","author":"N Iwami","year":"2018","unstructured":"Iwami N, Kawamata M, Ozawa N, Yamamoto T, Watanabe E, Moriwaka O, et al. New trial of progestin-primed ovarian stimulation using dydrogesterone versus a typical GnRH antagonist regimen in assisted reproductive technology. Arch Gynecol Obstet. 2018;298:663\u201371.","journal-title":"Arch Gynecol Obstet"},{"key":"1404_CR21","doi-asserted-by":"publisher","first-page":"31112","DOI":"10.1038\/srep31112","volume":"6","author":"X Lu","year":"2016","unstructured":"Lu X, Chen Q, Fu Y, Ai A, Lyu Q, Kuang YP. Elevated progesterone on the trigger day does not impair the outcome of human menotrophins gonadotrophin and Medroxyprogesterone acetate treatment cycles. Sci Rep. 2016;6:31112.","journal-title":"Sci Rep"},{"key":"1404_CR22","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.fertnstert.2019.06.009","volume":"112","author":"S Yildiz","year":"2019","unstructured":"Yildiz S, Turkgeldi E, Angun B, Eraslan A, Urman B, Ata B. Comparison of a novel flexible progestin primed ovarian stimulation protocol and the flexible gonadotropin-releasing hormone antagonist protocol for assisted reproductive technology. Fertil Steril. 2019;112:677\u201383.","journal-title":"Fertil Steril"},{"key":"1404_CR23","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1477-7827-12-10","volume":"12","author":"A Requena","year":"2014","unstructured":"Requena A, Cruz M, Ruiz FJ, Garc\u00eda-Velasco JA. Endocrine profile following stimulation with Recombinant follicle stimulating hormone and luteinizing hormone versus highly purified human menopausal gonadotropin. Reprod Biol Endocrinol. 2014;12:10.","journal-title":"Reprod Biol Endocrinol"},{"key":"1404_CR24","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s40618-016-0531-8","volume":"40","author":"VS Vanni","year":"2017","unstructured":"Vanni VS, Vigan\u00f2 P, Quaranta L, Pagliardini L, Giardina P, Molgora M, et al. Are extremely high progesterone levels still an issue in IVF? J Endocrinol Invest. 2017;40:69\u201375.","journal-title":"J Endocrinol Invest"},{"key":"1404_CR25","doi-asserted-by":"crossref","unstructured":"Chen ZQ, Zhang Y, Li H, Wang JY, Wang L, Ai A et al. A randomized controlled trial to compare the live birth rate of the first frozen embryo transfer following the progestin-primed ovarian stimulation protocol vs. the antagonist protocol in women with an anticipated high ovarian response. Fertil Steril 2024.","DOI":"10.1016\/j.fertnstert.2024.01.027"},{"key":"1404_CR26","doi-asserted-by":"publisher","first-page":"e2939","DOI":"10.1097\/MD.0000000000002939","volume":"95","author":"Y Wang","year":"2016","unstructured":"Wang Y, Chen Q, Wang N, Chen H, Lyu Q, Kuang Y. Controlled ovarian stimulation using Medroxyprogesterone acetate and hMG in patients with polycystic ovary syndrome treated for IVF: A Double-Blind randomized crossover clinical trial. Med (Baltim). 2016;95:e2939.","journal-title":"Med (Baltim)"},{"key":"1404_CR27","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1097\/GCO.0000000000000362","volume":"29","author":"B Ata","year":"2017","unstructured":"Ata B, Seli E. A universal freeze all strategy: why it is not warranted. Curr Opin Obstet Gynecol. 2017;29:136\u201345.","journal-title":"Curr Opin Obstet Gynecol"},{"key":"1404_CR28","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1093\/humrep\/deh765","volume":"20","author":"P Humaidan","year":"2005","unstructured":"Humaidan P, Bredkjaer HE, Bungum L, Bungum M, Gr\u00f8ndahl ML, Westergaard L, et al. GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF\/ICSI cycles: a prospective randomized study. Hum Reprod. 2005;20:1213\u201320.","journal-title":"Hum Reprod"}],"container-title":["Reproductive Biology and Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12958-025-01404-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12958-025-01404-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12958-025-01404-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T00:31:16Z","timestamp":1747096276000},"score":1,"resource":{"primary":{"URL":"https:\/\/rbej.biomedcentral.com\/articles\/10.1186\/s12958-025-01404-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,13]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1404"],"URL":"https:\/\/doi.org\/10.1186\/s12958-025-01404-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4877438\/v1","asserted-by":"object"}]},"ISSN":["1477-7827"],"issn-type":[{"value":"1477-7827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,13]]},"assertion":[{"value":"8 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board of Shanghai First Maternity and Infant Hospital (KS23157). Informed consent was obtained from all patients. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"67"}}